NEXTURNBIOSCIENCE Co., Ltd. (KOSDAQ:089140)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,325.00
+25.00 (1.09%)
Last updated: Mar 24, 2025

NEXTURNBIOSCIENCE Revenue

NEXTURNBIOSCIENCE had revenue of 9.89B KRW in the quarter ending September 30, 2024, a decrease of -3.53%. This brings the company's revenue in the last twelve months to 35.86B, down -7.32% year-over-year. In the year 2023, NEXTURNBIOSCIENCE had annual revenue of 41.26B with 75.84% growth.

Revenue (ttm)
35.86B
Revenue Growth
-7.32%
P/S Ratio
0.88
Revenue / Employee
555.09M
Employees
57
Market Cap
31.76B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202341.26B17.79B75.84%
Dec 31, 202223.46B6.49B38.24%
Dec 31, 202116.97B7.29B75.24%
Dec 31, 20209.69B-15.43B-61.43%
Dec 31, 201025.11B13.24B111.45%
Dec 31, 2009 Pro Pro Pro
Dec 31, 2008 Pro Pro Pro
Dec 31, 2007 Pro Pro Pro
Dec 31, 2006 Pro Pro Pro
Dec 31, 2005 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Samsung Electronics 300.87T
SK hynix 66.19T
LG Energy Solution 25.62T
Samsung Biologics 4,547.32B
Hyundai Motor Company 175.23T
Kia Corporation 107.45T
Celltrion 3,557.30B
KB Financial Group 15.01T
Revenue Rankings